Protective immunity to lethal Candida albicans challenge in vivo and activation of splenic macrophages with highly candidacidal activity in vitro were detected in mice infected with low-virulence agerminative yeast cells of the variant strain PCA-2, at a time when a strong delayed-type hypersensitivity (DTH) reaction to C. albicans occurred in the footpads of PCA-2-treated mice. The DTH reaction was transferable with spleen cell populations from these animals, and enrichment of splenic lymphocytes in L3T4+ cells significantly increased the footpad swelling. The reactivity transferred by L3T4+ cells was a radiosensitive (2,500 rads in vitro) phenomenon that required collaboration with radioresistant, silica-sensitive syngeneic cells in the host and was inhibited by treatment of recipient mice with antibodies to the L3T4 antigen or murine gamma interferon. In vitro, the PCA-2-immune L3T4+ cells produced various lymphokine activities upon incubation with C.
Infection with Candida albicans induces both humoral and cell-mediated immune responses against the yeast (38) . Anti-Candida antibodies confer only partial protection against experimental challenge, and cell-mediated immunity is thought to be a major factor in host resistance (33, 40) . Although the importance of T-cell-dependent immunity in chronic mucocutaneous candidosis has been clearly established (12, 29, 34, 50) , the protective role of this component of immunity in systemic candidosis has not been so well defined (13, 23, 46) . As a matter of fact, innate natural immune mechanisms appear to be most important in resistance to disseminated C. albicans infections, with a major role apparently being played by nonspecifically activated polymorphonuclear leukocytes (PMN) (2, 6, 23, 33, 47) and macrophages (1, 3, 5, 30, 43) .
The L3T4+ T-cell subset actively participates in the regulation of immunological and inflammatory processes involving the functions of professional phagocytes (24) . In experimental models of microbial infection, helper L3T4+ (or TH2) cells (11) appear to be essential for effective humoral immune responses to extracellular pathogens, while inflammatory L3T4+ T (or TH1) cells are responsible for T-cell-dependent macrophage activation and elimination of intracellular pathogens (9) . In most of these infection models, a common feature of host-protective inflammatory L3T4+ lymphocytes is their ability to release lymphokines that result in macrophage activation and development of a delayed-type hypersensitivity (DTH) reaction to microbial antigens (14, 21, 26, 28, 37, 41, 42) .
In a previously described model of systemic infection of mice with C. albicans, we have shown that protective * Corresponding author.
immunity to lethal challenge is induced by vaccinating the animals with low-virulence Candida cells of the agerminative variant strain PCA-2 (7) . In this model, the establishment of effective protection requires a period of 7 to 14 days after vaccination, is accompanied by a state of chronic infection involving a critical antigenic load (51) , and is apparently mediated by nonspecifically activated professional phagocytes with microbicidal properties (8) . Because of the reported occurrence of DTH reactions to Candida antigens (23) , in the present work we addressed the question of whether L3T4+ T-cell-dependent immunity could be detected in mice infected with PCA-2 and whether this event might participate in the anti-Candida resistance induced by vaccination. Our results suggest an important role for inflammatory L3T4+ cells as a cofactor of phagocytic cell activation, leading to an optimally protective response to C. albicans infection; however, they also suggest that compensatory mechanisms may provide substantial protection under conditions for which the activity of this T-cell subset is reduced.
MATERIALS AND METHODS
Mice. Hybrid (BALB/cCr x DBA/2Cr)F1 (CD2F1; H2dlH-2d) and inbred C57BL/6 (H-2b) mice were obtained from Charles River Breeding Laboratories, Calco, Milan, Italy. Both male and female mice ranging in age from 2 to 4 months were used.
Yeasts. The origin and characteristics of the two strains of C. albicans (CA-6 and PCA-2) used in this study have already been described in detail (7, 8, 51) . Briefly, the highly pathogenic strain CA-6 was isolated from a clinical specimen; the agerminative, low-virulence strain PCA-2 is an echinocandin-resistant mutant of the parent strain 3153A and was kindly supplied by D. Kerridge, Department of Biochemistry, University of Cambridge, Cambridge, England. All yeasts were grown to the stationary phase at 28°C under slight agitation in low-glucose Winge medium composed of 0.2% (wt/vol) glucose and 0.3% (wt/vol) yeast extract (BBL Microbiology Systems, Cockeysville, Md.). Under these conditions, cultures gave a yield of 2 x 108 to 4 x 108 cells per ml, and the organisms grew as an essentially pure yeast-phase population. After the 24-h culture, cells were harvested by low-speed centrifugation (1,000 x g), washed twice in saline, and diluted to the desired density.
DTH assay. A direct assay system for measuring the DTH response to cell surface antigens was used (44) , in which heat-inactivated CA-6 cells (2 x 106 cells per 0.04 ml of pyrogen-free saline) were inoculated into the footpads of mice that had been infected intravenously (i.v.) with 106 live PCA-2 cells a number of days before. In the DTH transfer experiments, CA-6 cells were injected into the footpads of mice that had been adoptively transferred, 24 h earlier, by i.v. administration of lymphocytes (107 lymphocytes per 0.5 ml of RPMI 1640 medium) from PCA-2-infected hosts. The DTH reaction was recorded 24 h later by weighing the footpad as a measure of swelling, and the results were expressed as the increase in right hind footpad weight over that of the saline-injected left hind counterpart. Data are the means ± standard errors for six to eight mice per group.
Positive selection of L3T4+ cells. Positive selection of L3T4+ cells was done as previously described (32, 44) . Briefly, B-cell-depeleted splenic lymphocytes from mice infected with PCA-2 14 days earlier (unless otherwise stated) were incubated with rat monoclonal anti-mouse L3T4 immunoglobulin G (IgG) antibody (GK 1.5; a generous gift from Frank Fitch, University of Chicago, Chicago, Ill.) for 40 min at 4°C. The cells were washed, resuspended, and placed in petri dishes coated with a goat anti-mouse IgG antiserum cross-reacting with rat antibody determinants (32) (a gift from M. Mage, National Institutes of Health, Bethesda, Md.). The nonadherent cells (>90% negative for L3T4 antigen on immunofluorescence analysis) were removed, and the plates were washed four times with phosphatebuffered saline. The attached cells were recovered by vigorous pipetting of Hanks balanced salt solution onto the cell layer, centrifuged, and suspended in RPMI 1640 medium supplemented with 5% heat-inactivated fetal calf serum. These cells (>98% positive for L3T4 antigen) were referred to as L3T4+ cells.
In vivo treatments with antibodies and silica. For assessment of the in vivo effects of monoclonal antibodies (MAbs) on the footpad reaction to C. albicans, mice were injected i.v. with 0.5 ml of GK 1.5 or R4-6A2 (ATCC HB 170) hybridoma culture supernatants by methods previously shown to affect the induction and expression of antigenspecific DTH responses (44) . Supernatants, which were taken at the time of medium exhaustion, centrifuged, and filtered, typically contained 8 to 10 ,ug of rat IgG antibody per ml, as measured in an enzyme-linked immunosorbent assay with an affinity-purified rat IgG antibody as a reference preparation of known titer (0.5 mg/ml). Silica (Santocel; Monsanto, St. Louis, Mo.) was dissolved in saline (5 mg/ml), heated in boiling water, and administered intraperitoneally to mice (3 mg per mouse) 24 h before adoptive transfer of lymphocytes. In a study of the effect of anti-L3T4 treatment on the in vivo resistance of mice to CA-6 challenge, the animals each received five injections of GK 1. Assays for lymphokine activity. Interleukin-2 (IL-2) activity was measured by its ability to sustain the growth of an IL-2-dependent line, (25) , by using the tetrazoliumbased colorimetric assay (35) . This assay, also used to assess the effect of other lymphokines on cell growth and survival, involves treating cells with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) at 37°C for 4 h, washing them with phosphate-buffered saline, solubilizing formazan crystals with acidified isopropanol, and reading the A540 with a microELISA reader. IL-2 titers were expressed as units per milliliter, which were calculated by comparing the dilutions of the test supernatant that gave 50% maximal stimulation of HT-2 proliferation with a standard preparation of IL-2 (1.5 x 106 U/ml; Cetus Corp., Emeryville, Calif.).
Culture supematants were analyzed for lymphotoxin (LT) activity as described previously (19) . Briefly, samples were serially diluted and added to mouse L929 cells. At 72 h later, cell survival was assessed and the percent cytotoxicity for each dilution was calculated. LT titers were expressed as units per milliliter, obtained by referring to the activity of a human recombinant LT preparation (1.2 x 108 U/ml; a gift of M. Mage).
Granulocyte-macrophage colony-stimulating factor (GM-CSF) activity was determined by its ability to sustain the growth of bone marrow cells in soft agar cultures (48) . Bone marrow cells (105 in 1 ml) were plated in 35-mm petri dishes, and 0.1-ml volumes of serial dilutions of the test supernatants were added. Granulocyte-macrophage CFU (>50 cells) were examined at x40 magnification. GM-CSF titers were expressed as units per milliliter by referring to the standard curve obtained with a recombinant GM-CSF preparation (2 protection of mouse L929 cells from the cytopathic effect of vesicular stomatitis virus as described by Palmer et al. (39) . Briefly, 0.1-ml of twofold dilutions of test supernatant and 5 x 104 L929 cells in 0.1 ml were incubated in flat-bottom microdilution plates for 18 to 24 at 37°C in a 5% CO2 incubator. Cultures were then drained, and the monolayers in each well were challenged with 50 p.1 of vesicular stomatitis virus (5 x 106 PFU/ml), resulting in complete cytopathic effect of unprotected cells within 48 h. IFN titers were expressed as units per milliliter, as estimated by reference to the standard curve established with a recombinant IFN-,y preparation (1 x 104 U/ml; Genentech Inc., South San Francisco, Calif.). In selected experiments, test supernatants to be assayed for antiviral activity were admixed with anti-IFN-y monoclonal antibody (R4-6A2 hybridoma culture supernatant; final dilutions, 1/200 to 1/4,000) before being incubated with L929 cells. This resulted, as a rule, in complete neutralization of the antiviral activity with antibody dilutions up to 1/2,000.
Irradiation. Mice were exposed to 800 rads of total-body irradiation before lymphocyte transfer, in a 'Co irradiator delivering gamma rays at 900 rads/min. The same 'Co bomb was used for irradiation of L3T4+ cells in vitro, at room temperature, in sealed glass vials. Statistical analysis. Differences in survival times were determined by the Mann-Whitney U test. Differences in the numbers of CFU in the kidneys were analyzed by Student's t test. The same test was performed on footpad weight increase values in the DTH experiments. Each experiment was performed at least three times.
RESULTS
Effect of PCA-2 injection on anti-Candida resistance, candidacidal activity of spleen cells, and delayed-type footpad reaction to Candida antigens. CD2F1 mice inoculated with live PCA-2 cells at different times were either challenged i.v. with 106 CA-6 cells or injected in the footpad with inactivated Candida cells to be assayed 24 h later for footpad swelling, as described in Materials and Methods. Additional groups of mice treated with PCA-2 served as donors of spleen cells to be reacted in vitro with Candida cells in a CFU inhibition assay. In line with our previous results (7), PCA-2 treatment conferred considerable protection against microbial challenge performed 10 to 14 days after vaccination, at a time when highly candidacidal effectors were found in the spleens of PCA-2-infected mice (Table 1) . Concurrent with maximal anti-Candida resistance was the detection of strong reactivity to Candida antigens in the footpads of sensitized mice. Histopathological evaluation of footpads indicated that the cellular response was predominantly mononuclear. Neither protective immunity nor DTH reactivity was detected in mice sensitized 14 days earlier with heat-inactivated CA-6 cells.
Transfer of DTH with spleen cells and L3T4+ lymphocytes. In mice, the inflammatory response known as DTH is mediated by T cells with the L3T4+ surface antigen phenotype. The possible involvement of L3T4+ lymphocytes in mediating DTH to C. albicans was investigated in experiments of adoptive transfer of DTH. By using the GK 1. Lymphokine secretion in vitro by PCA-2-immune L3T4+ cells. Lymphokine production, which accounts for much of the T-cell activity, correlates with functional phenotype in L3T4+ lymphocyte clones (24) . Of these cells, the ones predominantly involved in DTH reactions have been termed inflammatory T or THi (11) cells and are characterized by the release of a set of lymphokines (primarily IL-2, IFN--y, LT, and GM-CSF) upon antigen stimulation in vitro. We therefore attempted to identify lymphokine activity in the supernatants from PCA-2-immune lymphocytes cultured in vitro with inactivated CA-6 cells. Unfractionated splenic lymphocytes or positively selected L3T4+ cells mixed with syngeneic macrophages were cultured for 20 h with inactivated Candida cells before culture supernatants were tested for IL-2, LT, GM-CSF, and IFN--y activities, as described in Materials and Methods. The results of a typical experiment are given in Table 4 , which shows that all of these activities could be detected in supernatants from PCA-2-immune lymphocytes incubated with C. albicans. Minimal lymphokine activity was generated by L3T4+ cells in the absence of either third-party macrophages (data not shown) or stimulator CA-6 cells ( Table 4) .
Effect of anti-L3T4 administration on resistance to C. albicans. We next investigated the effect of in vivo anti-L3T4 treatment on the protective immunity induced by PCA-2 to CA-6 challenge. Mice treated with PCA-2 on day -14 received five daily i.v. injections (days -1 to +3) of GK 1.5 hybridoma culture supernatant (a total of approximately 25 pg of anti-L3T4 MAb per mouse) by using a procedure that had been shown in preliminary experiments to reduce the number of L3T4+ cells from approximately 30% to <1% in the spleens of the PCA-2-infected mice, as detected by immunofluorescence. On day 0, the animals were challenged with 5 x 105 CA-6 cells and then examined for mortality or the ability to clear Candida cells from their kidneys. Addi- cells from the kidneys. PCA-2-infected mice, treated with media (0) or GK 1.5 hybridoma culture supernatant (A), were challenged i.v. on day 0 with 5 x 105 CA-6 cells. On days 2, 4, and 10, the CA-6 titer in the kidneys was measured. Symbols: 0, control mice subjected to CA-6 challenge only (median survival time, 5 days); *, P < 0.01 (anti-L3T4-treated mice versus untreated controls); **, P < 0.01 (PCA-2-treated mice versus controls).
tional groups of mice, treated with PCA-2 and antibodies as described above but not subjected to microbial challenge, were either used as donors of splenocytes to be assayed in vitro for lymphokine activity or tested for DTH reactivity in vivo 24 h after the last anti-L3T4 antibody injection. MAb treatment significantly decreased the resistance of mice to Candida infection, in that more yeast cells were recovered from the kidneys of anti-L3T4-treated mice at days 2, 4, and 10 after infection (Fig. 2) . However, the majority of these mice eventually cleared viable Candida cells from their organs, and the outcome of challenge was not significantly different from that for control mice receiving medium (Table  5 ). In addition, the anti-L3T4 treatment completely blocked the development of a DTH reaction to inactivated Candida cells (Table 5) . Upon in vitro exposure to inactivated Can- (24) . Although L3T4+ cells may also exert disease-promoting effects under special conditions (20, 31) , the activity of THi inflammatory lymphocytes appears to be host protective in most experimental infection models and is associated with the detection of DTH reactions to microbial antigens (10, 14, 26, 28, 41, 42, 45) . Synthesis of IFN--y and other lymphokines (namely, IL-2, LT, IL-3, and GM-CSF) is a distinctive feature of THi inflammatory L3T4+ cells and is believed to play an important role in both induction of DTH and protective immunity to pathogens that inhabit macrophage vesicles (9, 21, 37) . Recently, major histocompatibiity complex class HIrestricted cytolytic T cells with the L3T4+ surface phenotype have been described, and it has been suggested that these cells may participate in host resistance to intracellular pathogens (27, 36) .
In C. albicans infections, mechanisms against the yeast are believed to involve specific T cells because patients with chronic mucocutaneous candidosis, malignancies, and immunodeficiency syndromes often display defective skin test DTH reactivity to Candida antigens and the T cells from a majority of these patients show no responsiveness to induction of proliferation by Candida antigen in vitro (38) . In resistance to disseminated candidosis, the role of T-celldependent immunity is more controversial (13, 23, 46) and nonspecifically activated phagocytes are undoubtedly most important in combating the infection (2, 6, 40, 47) . Because of the crucial involvement of T-cell-derived lymphokines in the regulation of phagocytic cell functions, it is possible that Candida-specific lymphocytes contribute to the activation of fungicidal effectors via the release of soluble mediators. In fact, DTH reactions are known to occur in response to Candida antigens (23) ; for this reason, in the present study we investigated the role of T inflammatory L3T4+ cells in resistance to systemic Candida infection in mice in which protective immunity had been induced by vaccination with low-virulence variant cells.
Our results indicated that the protection elicited by PCA-2 is indeed associated with the detection of DTH reactivity to CA-6 antigens, an effect transferable with L3T4+ lymphocytes from vaccinated mice. The kinetics of the emergence of this reactivity were so closely associated with those of emergence of protective immunity in the PCA-2-treated host that they suggested a causal relationship between the two phenomena. In agreement with previous results in other systems, the L3T4+ cells responsible for transfer of DTH appeared to be sensitive to radiation in vitro and to specific antibody in vivo, while they collaborated with radioresistant, silica-sensitive cells in the host (44) . Conceivably, the requirement for host-derived macrophages in our model serves two purposes. Accessory functions must be provided to immune L3T4+ lymphocytes by syngeneic antigen-pre- The set of lymphokine activities produced in vitro by L3T4+ cells in response to C. albicans included IL-2, LT, GM-CSF, and IFN--y, all of which are known to be produced by THi inflammatory lymphocytes. LT, GM-CSF, and IFN--y all have profound effects on the functions of PMN and macrophagic cells. Increased GM-CSF production may account for the marked augmentation in the number of PMN and macrophages that occurs in the peripheral blood and spleens of mice injected with PCA-2, as previously reported (7, 8, 51) . GM-CSF activates mature granulocytes (16) and cooperates with IFN--y for induction of resistance to infection (4). IFN-,y, on the other hand, is a most potent macrophage activator (21, 49) and activates human PMN to candidacidal effectors (17) . LT and tumor necrosis factor, a cytokine with substantial homology to LT, facilitate macrophage activation (22) and exert PMN-mediated candidacidal activity (17) . These considerations, together with the results of previous studies in which a variety of pathogens were used (9, 10, 26, 28, 41, 42, 45) , suggest that L3T4+ cells provide a substantial contribution to host defense against infection with C. albicans.
To substantiate this hypothesis, we performed experiments involving selective depletion in vivo of L3T4+ cells by using the specific MAb GK 1.5; this antibody, besides blocking the expression of adoptively transferred DTH reactivity to C. albicans as described above, has been extensively used in the past to study the in vivo role of L3T4+ cells in a variety of experimental systems (for a review, see reference 14) . Surprisingly enough, we found that although anti-L3T4 administration significantly impaired host resistance to C. albicans, DTH reactivity, and lymphokine production in vitro, most of the infected mice eventually cleared the yeast from their kidneys in a manner that was only delayed compared with that in non-antibody-treated control mice. Similar results were obtained by Czuprynski et al., who studied the effect of anti-L3T4 treatment on mouse resistance to Listeria monocytogenes infection (14) . On the basis of the clearing rate of the listeriae from the organs of antibody-treated animals, these authors concluded that compensatory mechanisms allowed anti-L3T4-treated mice to eliminate the pathogen in a retarded but otherwise relatively normal fashion. Our present data are in agreement with such previous findings and also support the same conclusions. Undoubtedly, the nature of the compensatory mechanisms operating in our infection model remains to be determined. One possibility is that lymphokines with substantial activity on phagocytic cell functions are produced by L3T4-T (15) or non-T (18) lymphocytes when the activity of L3T4+ cells is deficient. In this regard, it should be noted that in a previous study in which congenitally athymic mice (which are known to express high spontaneous levels of macrophage activation [13] ) were used, PCA-2 treatment protected 50% of the vaccinated mice against CA-6 challenge (8).
In conclusion, our present data suggest that specifically immune L3T4+ cells contribute to optimally protective immunity to systemic Candida infection through the intervention of soluble, possibly interactive mediators which cooperate to activate phagocytic cells with candidacidal activity. However, there is no absolute requirement for the lymphokines secreted by the PCA-2-immune T-inflammatory lymphocytes for the vaccine to be effective, since selective depletion of L3T4+ cells only delays the elimination of yeast cells from the mouse organs. In addition, our data call attention to the notion that resistance to systemic candidosis does not necessarily correlate with expression of L3T4+ cell-dependent activities, such as DTH (23) or lymphocyte activation in vitro in response to Candida antigen.
